Article may be outdated

This article is 10 days old. Some details may have changed since publication.

BBC News·3 min read·medium

There's finally a treatment for my five-year-old's dementia - but it'll cost me £3m

H
https://www.facebook.com/bbcnews
There's finally a treatment for my five-year-old's dementia - but it'll cost me £3m
✦AI Summary

A mother in Wales is struggling to fund a £3 million gene therapy treatment for her five-year-old son diagnosed with Sanfilippo Syndrome. While the treatment was recently approved in the US, the high cost and lack of international access pathways leave families outside the US in a precarious position.

Why it matters

It highlights the growing disparity in global healthcare access for rare diseases and the ethical challenges surrounding the pricing of life-saving gene therapies.

✦Dive DeeperCreate a free account to unlock

Image source, Tammy McDaid Image caption, Tate's mum Tammy McDaid needs £3m for life-saving treatment for her child

The mum of a five-year-old boy with a rare form of dementia has to pay almost £3m for his life saving treatment.

Tate McDaid, from Swansea, was diagnosed with Sanfilippo Syndrome - a form of dementia that just over 100 UK children have - when he was four .

In September, the first gene therapy to treat the condition in children was approved in the US.

His mum Tammy said she spent "months praying" for its approval but discovered the treatment is to set cost £2.95 million per child, with it unclear how families outside the US can fund this.

Health officials from Wales are currently talking to those in the US to see what potential access pathways there are for Tate.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthscienceworld
✦

Get smarter about the news

Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.

Create free account

Already have an account? Sign in